Medesis Pharma (STU:76D) EPS (Basic) : €-0.63 (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Medesis Pharma EPS (Basic)?

Medesis Pharma's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €-0.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.63.

Medesis Pharma's EPS (Diluted) for the six months ended in Jun. 2024 was €-0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.63.

Medesis Pharma's EPS without NRI for the six months ended in Jun. 2024 was €-0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.63.

During the past 3 years, the average EPS without NRI Growth Rate was -58.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -32.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Medesis Pharma's highest 3-Year average EPS without NRI Growth Rate was -34.90% per year. The lowest was -58.30% per year. And the median was -35.40% per year.

Medesis Pharma EPS (Basic) Historical Data

The historical data trend for Medesis Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma EPS (Basic) Chart

Medesis Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.46

-0.19

-0.61

-0.63

-0.80

Medesis Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial						-0.36	-0.27	-0.37	-0.47	-0.15

Medesis Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medesis Pharma's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.959	-	0)	/	4.960
	=	-0.80

Medesis Pharma's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.791	-	0)	/	5.147
	=	-0.15

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.63

Medesis Pharma (STU:76D) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medesis Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medesis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (STU:76D) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

ALMDP:France 76D:Germany

Address

Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670

Website

https://www.medesispharma.com

Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines